DAKAR (Reuters) - Liberia will receive enough of an experimental Ebola drug to treat just two infected Liberian doctors, Information Minister Lewis Brown said, after the U.S. Food and Drug Administration (FDA) approved its export.
Brown said Liberia's Health Ministry had contacted the U.S. manufacturer of ZMapp, Mapp Biopharmaceutical, and asked the FDA to quickly approve its export.
The doctors had consented in writing to the treatment, the minister said.
(Reporting by Daniel Flynn, editing by John Stonestreet)
Relacionados
- EEUU aprueba el uso del fármaco experimental contra el ébola en Liberia
- U.S. missionaries returning from Ebola-stricken Liberia quarantined
- Liberia president apologises for high toll for Ebola health workers
- Guinea shuts borders with Sierra Leone, Liberia in bid to halt Ebola
- Guinea cierra a causa del ébola sus fronteras terrestres con Liberia y Sierra Leona (gobierno)
